Psoriatic arthritis

No difference in persistence rates for subcutaneous TNFi

Rates of medication persistence are similar for subcutaneous TNF inhibitors in a range of inflammatory rheumatic disorders, a ‘real world’ Australian study has shown. After four years there were no significant differences in the proportion of patients persisting with different TNF inhibitors, data from 3749 biologic-naïve patients with RA, ankylosing spondylitis, psoriatic arthritis or undifferentiated ...

Already a member?

Login to keep reading.

© 2021 the limbic